4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-011867
Chairman and CEO acquired 454 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KAZIMI A J Chairman and CEO | 2024-06-13 | Other acquisition 10b5-1 | +25 | $1.52 | $38 | 5,695,582 | D |
| KAZIMI A J Chairman and CEO | 2024-06-14 | Other acquisition 10b5-1 | +48 | $1.50 | $72 | 5,695,630 | D |
| KAZIMI A J Chairman and CEO | 2024-06-17 | Other acquisition 10b5-1 | +41 | $1.49 | $61 | 5,695,671 | D |
| KAZIMI A J Chairman and CEO | 2024-06-18 | Other acquisition 10b5-1 | +41 | $1.57 | $64 | 5,695,712 | D |
| KAZIMI A J Chairman and CEO | 2024-06-20 | Other acquisition 10b5-1 | +41 | $1.53 | $63 | 5,695,753 | D |
| KAZIMI A J Chairman and CEO | 2024-06-21 | Other acquisition 10b5-1 | +41 | $1.49 | $61 | 5,695,794 | D |
| KAZIMI A J Chairman and CEO | 2024-06-24 | Other acquisition 10b5-1 | +44 | $1.59 | $70 | 5,695,838 | D |
| KAZIMI A J Chairman and CEO | 2024-06-25 | Other acquisition 10b5-1 | +44 | $1.54 | $68 | 5,695,882 | D |
| KAZIMI A J Chairman and CEO | 2024-06-26 | Other acquisition 10b5-1 | +44 | $1.50 | $66 | 5,695,926 | D |
| KAZIMI A J Chairman and CEO | 2024-06-27 | Other acquisition 10b5-1 | +44 | $1.52 | $67 | 5,695,970 | D |
| KAZIMI A J Chairman and CEO | 2024-06-28 | Other acquisition 10b5-1 | +41 | $1.50 | $62 | 5,696,011 | D |
Loading xslF345X05/marketforms-66482.xml…